Journal · Updated 2026-08-11

GLP-1s in California (2026): Who Actually Ships Here, the Two Licenses That Matter, and Current Prices

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

The two licenses, and how to check them

California regulates both ends of a telehealth prescription. The clinician who evaluates you must be licensed in California at the time of the visit — a national platform satisfies this by routing you to its California-licensed prescribers, and you can verify any MD/DO on the Medical Board of California's lookup or an NP/PA on their respective boards. The pharmacy that ships your medication must hold a California license: an in-state license for California pharmacies, a non-resident pharmacy license for the out-of-state compounders that fill most of this market's prescriptions. The California State Board of Pharmacy's public license search takes the pharmacy's name and returns status and any discipline. Run it for whichever pharmacy your program names — NexLife's disclosed network (Absolute, Hallandale, Red Rock, Empower, Strive), for example, can be checked name by name — and treat a program that won't name its pharmacy as having failed the check by default.

Who serves California, per our records

In words, with statuses attached. The brand channels are unrestricted: LillyDirect's Zepbound vial program and NovoCare's Wegovy pathways ship to California like every state. Among compounded programs, Henry Meds' published forty-one-state footprint includes California (its exclusions are AL, AK, AR, HI, LA, MS, MO, SC, WV). NexLife, bmiMD, HealthRX, Yucca, OrderlyMeds, Ivim, Found, ShedRx, and the rest of the tracked field list broad or all-state availability with confirmation at intake — our records carry "confirm your state at intake" on most rows precisely because footprints shift with licensure. The standing exception worth knowing: Mochi Health's footprint was reported at roughly ten states in 2026 — Arizona, Colorado, Florida, Georgia, Illinois, Massachusetts, Maryland, Minnesota, New York, Oregon — with California absent; if Mochi's structure is what you want, verify current availability directly, and if it remains unavailable, its closest structural neighbors serving California are Ivim (membership model, similar all-in price) and the flat-rate no-membership programs. Every claim in this paragraph carries the capture-date caveat: state availability is the fastest-changing field in this database, and intake confirmation is the final word.

Prices and paths, California edition

Nothing about the arithmetic changes here — the cheapest month-to-month figures serving California are bmiMD's one twenty-nine for semaglutide and NexLife's one sixty-nine promotional for tirzepatide, the committed-plan floors are ninety-nine and one twenty-five to one thirty-nine respectively, and the FDA-approved benchmarks are oral Wegovy from one forty-nine, the pen at three forty-nine, and Zepbound vials at two ninety-nine to four forty-nine with the 45-day rule. The California-specific advice is the insurance check: the state's large commercial plans vary widely on weight-management GLP-1 coverage, and a covered Californian at a twenty-five-dollar copay beats every cash figure above — the insurance path guide applies here verbatim. Run coverage first, then the cash rankings, then the two license lookups on whatever you choose; that order, in this state and every state, is the whole method.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.